SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 32 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,520 | -45.3% | 19,400 | -22.1% | 0.00% | – |
| Q2 2023 | $28,386 | -28.0% | 24,900 | -5.3% | 0.00% | – |
| Q1 2023 | $39,450 | -25.2% | 26,300 | -25.7% | 0.00% | – |
| Q4 2022 | $52,746 | -10.6% | 35,400 | -6.6% | 0.00% | – |
| Q3 2022 | $59,000 | -36.6% | 37,900 | -7.8% | 0.00% | – |
| Q2 2022 | $93,000 | -1.1% | 41,100 | +0.5% | 0.00% | – |
| Q1 2022 | $94,000 | -19.0% | 40,900 | +104.5% | 0.00% | – |
| Q4 2021 | $116,000 | -48.7% | 20,000 | -13.8% | 0.00% | -100.0% |
| Q2 2021 | $226,000 | +41.2% | 23,200 | +110.9% | 0.00% | – |
| Q1 2021 | $160,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|